An experimental treatment protects mice from COVID-19, flu, bacteria, and more.

The vaccine could replace the need for separate annual jabs for flu, Covid and cold viruses as well as providing defence ...

An infectious disease specialist took the time to explain what herd immunity is, how it works and when it might affect the spread of COVID-19. Dr. Frank Esper works for the Cleveland Clinic Children's ...

To help answer common vaccine questions, we consulted Dr. Stanley Perlman, a professor at the University of Iowa’s Carver College of Medicine and a member of the U.S. Food and Drug Administration’s ...

European regulators advanced several new medicines, including a combined flu and COVID vaccine and new treatments for rare diseases.

Federal investment in RNA vaccine research has supported nearly three decades of scientific work spanning infectious diseases, cancer, and vaccine development, but recent and proposed funding cuts ...

Pfizer and BioNTech, makers of the Food and Drug Administration-approved COVID-19 vaccine Comirnaty, shared today that their vaccine is effective among children ages 5 to 11 and that they will seek ...

European regulators cleared Moderna’s first-of-its-kind vaccine as US approval remains uncertain. On Friday, Moderna’s ...

A healthcare worker places vials containing doses of the "Comirnaty" Pfizer BioNTech and Moderna vaccines against the coronavirus disease (COVID-19) on a table at a vaccination centre in Ronda, Spain ...

Scientists have uncovered the precise molecular trigger behind a rare blood-clotting disorder linked to certain COVID-19 vaccines.

By Kamal Choudhury and Blake Brittain March 3 (Reuters) - Moderna has agreed to pay Genevant Sciences, a subsidiary of ...